Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Am J Med ; 136(3): 234-243, 2023 03.
Article in English | MEDLINE | ID: mdl-36495937

ABSTRACT

Monkeypox, a neglected disease previously confined to Africa, is causing a worldwide outbreak affecting predominantly males who have sex with males, especially those who are infected with HIV. The clinical presentation during the current outbreak differs from endemic cases. Treatment with tecovirimat and other antivirals is available. Immunization may be used as preexposure and postexposure prophylaxis.


Subject(s)
Mpox (monkeypox) , Sexual and Gender Minorities , Male , Humans , Female , Mpox (monkeypox)/diagnosis , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/prevention & control , Homosexuality, Male , Antiviral Agents/therapeutic use , Benzamides
3.
Trans R Soc Trop Med Hyg ; 115(9): 941-943, 2021 09 03.
Article in English | MEDLINE | ID: mdl-33991414

ABSTRACT

COVID-19 infections have spread widely in Peru, causing severe societal and health impact. We describe the evolution of the epidemics, the reasons for high transmission and the way the disease is diagnosed and managed in the Andean country.


Subject(s)
COVID-19 , Epidemics , Humans , Peru/epidemiology , SARS-CoV-2
5.
Am J Med ; 128(7): 682-91, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25731139

ABSTRACT

Ebola virus caused an epidemic of unprecedented extension in West Africa. There was concern that the outbreak would not be controlled for a prolonged period of time. Two cases of infected returning travelers have been reported in the US. One of the cases has been associated with secondary transmission and other infected subjects have been repatriated for treatment. This article reviews the etiology, pathogenesis, transmission, clinical manifestations, diagnosis, treatment, and prevention of the disease with emphasis on the identification and management in the US.


Subject(s)
Communicable Diseases, Emerging/epidemiology , Disease Outbreaks/statistics & numerical data , Disease Transmission, Infectious/statistics & numerical data , Hemorrhagic Fever, Ebola/epidemiology , Travel , Africa, Western/epidemiology , Communicable Disease Control/organization & administration , Communicable Diseases, Emerging/prevention & control , Disease Outbreaks/prevention & control , Disease Transmission, Infectious/prevention & control , Female , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/transmission , Humans , Incidence , Male , Risk Assessment , Survival Analysis , United States/epidemiology
6.
Med Hypotheses ; 74(1): 45-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19665314

ABSTRACT

Human bartonellosis is a South American anthroponosis caused by Bartonella bacilliformis. The disease has an acute phase characterized by invasion of red blood cells by parasites, and consequent severe anemia; and a chronic phase presenting with benign vascular tumors. During the acute phase, affected individuals are prone to developing opportunistic infections with a variety of organisms similar to the ones seen in AIDS. After antibiotic treatment is instituted, a subgroup of patients may develop atypical symptoms which potentially represent clinical manifestations of the restoration of macrophage function. We speculate that the pathophysiology of the acute phase of human bartonellosis resembles AIDS, with a period of immunosuppression following the infection and later, clinical manifestations of immune reconstitution subsequent to treatment.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , Bartonella Infections/diagnosis , Bartonella Infections/physiopathology , Acquired Immunodeficiency Syndrome/physiopathology , Animals , Anti-Infective Agents/pharmacology , Bartonella Infections/epidemiology , Diagnosis, Differential , Erythrocytes/cytology , Humans , Immune System , Immunosuppressive Agents/pharmacology , Immunosuppressive Agents/therapeutic use , Inflammation , Macrophages/metabolism , Models, Biological , Models, Theoretical , South America
9.
J Health Care Poor Underserved ; 20(4): 982-95, 2009 Nov.
Article in English | MEDLINE | ID: mdl-20168012

ABSTRACT

OBJECTIVE: To determine the prognostic influence of race/ethnicity on survival among patients infected with HIV infection. BACKGROUND: In the U.S., HIV infection occurs disproportionately in minority communities. Additionally, worse outcomes (including higher mortality) have been reported, particularly among African Americans. METHODS: This was a retrospective cohort study among 870 HIV-infected patients attending a Midwestern academic medical center. The study determined individual characteristics that were predictive of survival by using log rank tests and multivariate analysis models, after adjusting for known predictors of outcome. RESULTS: Low CD4 cell count (<100 cells/mm3), high viral load (>250,000 copies/mL), age older than 30, and Black race were independently predictive of poorer outcomes among patients infected with HIV. CONCLUSION: We found a large disparity in survival, with African Americans with advanced disease more likely to die than whites. This finding was not explained by socioeconomic status or other confounders. Future prospective studies are warranted.


Subject(s)
HIV Infections/ethnology , Health Status Disparities , Adult , Age Factors , CD4 Lymphocyte Count , Female , HIV Infections/mortality , Humans , Male , Midwestern United States/epidemiology , Multivariate Analysis , Prognosis , Retrospective Studies , Risk Factors , Survival Rate , Viral Load
10.
Braz. j. infect. dis ; 12(6): 531-535, Dec. 2008. tab
Article in English | LILACS | ID: lil-507456

ABSTRACT

Poor immune status, the use of a vascular access different from an AV fistula, and intravenous drug use (IDU) may favor increased rates of vascular access infections among HIV infected patients on hemodialysis. Staphylococcus spp. and Streptococcus spp. are the main cause of these infections, but Gram-negative rods and fungi have been found as well. Using an AV fistula when possible, and eliciting a history of IVDU on every visit may prevent this type of infection. When infections are present, coverage for both Gram-positive and negative organisms is recommended. Additional studies specifically addressing the issue of vascular access infection in HIV infected patients are required.


Subject(s)
Adult , Humans , Male , Catheterization, Central Venous/adverse effects , HIV Infections/complications , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Renal Dialysis/adverse effects , Staphylococcal Infections/etiology , Kidney Failure, Chronic/therapy , Risk Factors , Staphylococcal Infections/diagnosis
11.
Am J Med ; 121(10): 835-44, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18823850

ABSTRACT

Extensively drug-resistant tuberculosis (XDR-TB) is defined as Mycobacterium tuberculosis infection that is resistant to isoniazid, rifampin, any fluoroquinolone, and any injectable drug (amynoglicosides or polypetides). Although initially described in South Africa, it has emerged as a global threat, and cases have been reported from several countries, including the United States. XDR-TB has emerged mainly as a consequence of previous inadequate or poorly administered treatment, from failure of the public health infrastructure. As the diagnosis of this condition requires antibiotic susceptibility confirmation, a broad network of reference laboratories and the development of faster and more accurate tests for the identification of active cases of tuberculosis are urgently required. The treatment of XDR-TB is challenging and requires the use of multiple second-line drugs and, potentially, surgery. Infection control measures do not differ from those used for susceptible cases but may require more stringent application.


Subject(s)
Extensively Drug-Resistant Tuberculosis/therapy , Antitubercular Agents/therapeutic use , Extensively Drug-Resistant Tuberculosis/complications , Extensively Drug-Resistant Tuberculosis/diagnosis , Extensively Drug-Resistant Tuberculosis/epidemiology , HIV Infections/complications , Humans , Internationality
12.
Braz J Infect Dis ; 12(6): 531-5, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19287844

ABSTRACT

Poor immune status, the use of a vascular access different from an AV fistula, and intravenous drug use (IDU) may favor increased rates of vascular access infections among HIV infected patients on hemodialysis. Staphylococcus spp. and Streptococcus spp. are the main cause of these infections, but Gram-negative rods and fungi have been found as well. Using an AV fistula when possible, and eliciting a history of IVDU on every visit may prevent this type of infection. When infections are present, coverage for both Gram-positive and negative organisms is recommended. Additional studies specifically addressing the issue of vascular access infection in HIV infected patients are required.


Subject(s)
Catheterization, Central Venous/adverse effects , HIV Infections/complications , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Renal Dialysis/adverse effects , Staphylococcal Infections/etiology , Adult , Humans , Kidney Failure, Chronic/therapy , Male , Risk Factors , Staphylococcal Infections/diagnosis
13.
J Am Board Fam Med ; 20(6): 540-7, 2007.
Article in English | MEDLINE | ID: mdl-17954861

ABSTRACT

Newly developed assays that measure the production of cellular interferon gamma are useful diagnostic tools for the diagnosis of tuberculosis and may potentially replace or complement the tuberculin skin test in some circumstances. Importantly, interferon gamma release assays are more specific than tuberculin skin tests. Unfortunately the tests do not differentiate between active or latent infection. In addition, immunocompromised patients are more likely to have indeterminate results. The current interferon gamma release assays test approved in the United States is costly and requires drawing blood and processing within 12 hours of collection. This study discusses the potential benefits and drawbacks in patients, including those who are immunocompromised.


Subject(s)
Interferon-gamma , Tuberculin Test , Tuberculosis/diagnosis , Clinical Laboratory Techniques , Enzyme-Linked Immunosorbent Assay , Evidence-Based Medicine , Humans , Immunologic Tests , Immunosuppression Therapy , Reagent Kits, Diagnostic
14.
Wilderness Environ Med ; 18(3): 203-5, 2007.
Article in English | MEDLINE | ID: mdl-17896846

ABSTRACT

Imported human paragonimiasis has been reported in the United States. However, autochthonous cases are rare. We describe a case of probable Paragonimus kellicotti infection associated with ingestion of crayfish and review all autochthonous cases in this country.


Subject(s)
Lung Diseases, Parasitic/diagnosis , Paragonimiasis/diagnosis , Aged , Animals , Astacoidea/parasitology , Fatal Outcome , Food Microbiology , Humans , Lung Diseases, Parasitic/complications , Lung Diseases, Parasitic/pathology , Male , Nebraska , Paragonimiasis/complications , Paragonimiasis/pathology , Paragonimus/isolation & purification , Shock, Septic/etiology
15.
Am J Trop Med Hyg ; 77(2): 347-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17690410

ABSTRACT

Human neurotrichinellosis is seldom reported. This is likely the result of the low incidence of parasites from the genus Trichinella in the United States domestic food supply, as well as difficulties in diagnosing the disease, especially when neither the organism nor the source of the infection are readily available. Although trichinellosis from domestic food supplies has been decreasing for many years, a resurgence has occurred in cases derived from the consumption of wild game. We report a rare case of neurotrichinellosis in the United States and implicate wild game as the source of the infection. These results suggest that clinicians should consider the potential for Trichinella infection in cases where wild game is common in the diets of the patients.


Subject(s)
Nervous System Diseases/parasitology , Trichinella/growth & development , Trichinellosis/diagnosis , Animals , Animals, Wild/parasitology , Female , Humans , Middle Aged , Nebraska , Nervous System Diseases/diagnosis , Trichinellosis/parasitology
19.
Jpn J Infect Dis ; 59(2): 129-31, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16632916

ABSTRACT

Trichosporon fungemia is usually seen in neutropenic patients with underlying hematological malignancies. In this report we describe a fatal case of Trichosporon asahii fungemia in a non-neutropenic patient with a non-hematological malignancy. For 1 week the patient exhibited hematuria, weakness, easy fatigability and headaches. At admission she had anemia, renal failure and evidence of right hydronephrosis and bladder wall masses as detected by CT scan. She did not have a history of tobacco abuse, contact with urinary carcinogens or Schistosoma infestation; her clinical picture was suggestive of bladder cancer. After some investigations the patient underwent radical cystectomy and ileal conduit surgery because of transitional cell carcinoma in the urinary bladder. After an initial uneventful improvement postoperatively the patient deteriorated and died of septic shock despite all reanimation efforts and antibiotherapy including fluconazole. The blood culture obtained 4 days before the patient died revealed T. asahii, which was isolated on the day she died and found to be resistant to fluconazole and caspofungin. This report suggests that clinicians remain aware that T. asahii fungemia may develop in clinically deteriorated patients even if they do not have a hematological malignancy.


Subject(s)
Antifungal Agents/therapeutic use , Fungemia/diagnosis , Trichosporon/isolation & purification , Aged , Carcinoma, Transitional Cell/complications , Carcinoma, Transitional Cell/surgery , Caspofungin , Cystectomy/methods , Drug Resistance, Multiple, Fungal , Echinocandins , Fatal Outcome , Female , Fluconazole/therapeutic use , Fungemia/drug therapy , Fungemia/pathology , Humans , Lipopeptides , Microbial Sensitivity Tests , Peptides, Cyclic/therapeutic use , Trichosporon/drug effects , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/surgery
20.
Med Teach ; 28(1): 77-80, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16627329

ABSTRACT

Physicians in postgraduate training are expected to learn research methods but how best to achieve that curricular goal is unclear. This article describes a novel educational approach to develop research skills among infectious disease fellows. Five infectious disease fellows and two faculty members participated in a collaborative research project as a vehicle for active, problem-based learning. During the learning experience several tasks with specific learning objectives were achieved. The authors evaluated the weaknesses and strengths of the collaborative research project as an educational program. This problem-based approach for learning research methods seems more effective than traditional methods and may be applicable to a broad range of training programs.


Subject(s)
Education, Medical, Continuing/methods , Problem-Based Learning/methods , Research/education , Cohort Studies , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Communicable Disease Control/standards , Communicable Diseases , Cooperative Behavior , Education, Medical, Continuing/organization & administration , Fellowships and Scholarships , Guideline Adherence/statistics & numerical data , Illinois , Internal Medicine/organization & administration , Referral and Consultation , Research Design
SELECTION OF CITATIONS
SEARCH DETAIL
...